<?xml version="1.0" encoding="UTF-8"?>
<ref id="B103-pharmaceuticals-12-00060">
 <label>103.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Sacramento</surname>
    <given-names>C.Q.</given-names>
   </name>
   <name>
    <surname>De Melo</surname>
    <given-names>G.R.</given-names>
   </name>
   <name>
    <surname>De Freitas</surname>
    <given-names>C.S.</given-names>
   </name>
   <name>
    <surname>Rocha</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Hoelz</surname>
    <given-names>L.V.B.</given-names>
   </name>
   <name>
    <surname>Miranda</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Fintelman-Rodrigues</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Marttorelli</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Ferreira</surname>
    <given-names>A.C.</given-names>
   </name>
   <name>
    <surname>Barbosa-Lima</surname>
    <given-names>G.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication</article-title>
  <source>Sci. Rep.</source>
  <year>2017</year>
  <volume>7</volume>
  <fpage>40920</fpage>
  <pub-id pub-id-type="doi">10.1038/srep40920</pub-id>
  <?supplied-pmid 28098253?>
  <pub-id pub-id-type="pmid">28098253</pub-id>
 </element-citation>
</ref>
